1 / 31

Comparing I > 2 Groups - Numeric Responses

Comparing I > 2 Groups - Numeric Responses. Extension of Methods used to Compare 2 Groups Independent and Dependent Samples Normal and non-normal data structures. Independent Samples - Completely Randomized Design (CRD).

phyllis
Download Presentation

Comparing I > 2 Groups - Numeric Responses

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Comparing I > 2 Groups - Numeric Responses • Extension of Methods used to Compare 2 Groups • Independent and Dependent Samples • Normal and non-normal data structures

  2. Independent Samples - Completely Randomized Design (CRD) • Controlled Experiments - Subjects assigned at random to one of the I treatments to be compared • Observational Studies - Subjects are sampled from I existing groups • Statistical model xij is a subject from group i: where miis the population mean of group/treatment i , eij is a random error

  3. 1-Way ANOVA for Normal Data (CRD) • For each group obtain the mean, standard deviation, and sample size: • Obtain the overall mean and sample size

  4. Analysis of Variance - Sums of Squares/Degrees of Freedom • Total Variation • Among Group Variation • Within Group Variation

  5. Analysis of Variance Table and F-Test • H0: No differences among Group Means (m1==mI) • HA: Group means are not all equal (Not all mi are equal)

  6. Example - Relaxation Music in Patient-Controlled Sedation in Colonoscopy • Three Conditions (Treatments): • Music and Self-sedation (i = 1) • Self-Sedation Only (i = 2) • Music alone (i = 3) • Outcomes • Patient satisfaction score (all 3 conditions) • Amount of self-controlled dose (conditions 1 and 2) Source: Lee, et al (2002)

  7. Example - Relaxation Music in Patient-Controlled Sedation in Colonoscopy • Summary Statistics and Sums of Squares Calculations:

  8. Example - Relaxation Music in Patient-Controlled Sedation in Colonoscopy • Analysis of Variance and F-Test for Treatment effects • H0: No differences among Group Means (m1=m2=m3) • HA: Group means are not all equal (Not all mi are equal)

  9. Post-hoc Comparisons of Treatments • If differences in group means are determined from the F-test, researchers want to compare pairs of groups. Three popular methods include: • Dunnett’s Method - Compare active treatments with a control group. Consists of I-1 comparisons, and utilizes a special table. • Bonferroni’s Method - Adjusts individual comparison error rates so that all conclusions will be correct at desired confidence/significance level. Any number of comparisons can be made. • Tukey’s Method - Specifically compares all I(I-1)/2 pairs of groups. Utilizes a special table.

  10. Bonferroni’s Method (Most General) • Wish to make C comparisons of pairs of groups with simultaneous confidence intervals or 2-sided tests • Want the overall confidence level for all intervals to be “correct” to be 95% or the overall type I error rate for all tests to be 0.05 • For confidence intervals, construct (1-(0.05/C))100% CIs for the difference in each pair of group means (wider than 95% CIs) • Conduct each test at a=0.05/C significance level (rejection region cut-offs more extreme than when a=0.05)

  11. Bonferroni’s Method (Most General) • Simultaneous CI’s for pairs of group means: • If entire interval is positive, conclude mi > mj • If entire interval is negative, conclude mi < mj • If interval contains 0, cannot conclude mi mj

  12. Example - Relaxation Music in Patient-Controlled Sedation in Colonoscopy • C=3 comparisons: 1 vs 2, 1 vs 3, 2 vs 3. Want all intervals to contain true difference with 95% confidence • Will construct (1-(0.05/3))100% = 98.33% CIs for differences among pairs of group means Note all intervals contain 0, but first is very close to 0 at lower end

  13. CRD with Non-Normal Data Kruskal-Wallis Test • Extension of Wilcoxon Rank-Sum Test to I>2 Groups • Procedure: • Rank the observations across groups from smallest (1) to largest (N = n1+...+nI), adjusting for ties • Compute the rank sums for each group: R1,...,RI . Note that R1+...+RI = N(N+1)/2

  14. Kruskal-Wallis Test • H0: The I population distributions have same distribution • HA: Not all I distributions are identical Post-hoc comparisons of pairs of groups can be made by pairwise application of rank-sum test with Bonferroni adjustment

  15. Example - Thalidomide for Weight Gain in HIV-1+ Patients with and without TB • I=4 Groups, n1=n2=n3=n4=8 patients per group (N=32) • Group 1: TB+ patients assigned Thalidomide • Group 2: TB- patients assigned Thalidomide • Group 3: TB+ patients assigned Placebo • Group 4: TB- patients assigned Placebo • Response - 21 day weight gains (kg) -- Negative values are weight losses Source: Klausner, et al (1996)

  16. Example - Thalidomide for Weight Gain in HIV-1+ Patients with and without TB

  17. Weight Gain Example - SPSS OutputF-Test and Post-Hoc Comparisons

  18. Weight Gain Example - SPSS OutputF-Test and Post-Hoc Comparisons

  19. Weight Gain Example - SPSS OutputKruskal-WallisH-Test

  20. Dependent Samples: Randomized Block Design (RBD) • I > 2 Treatments (groups) to be compared • J individuals receive each treatment (preferably in random order). Subjects are called Blocks. • Outcome when Treatment i is assigned to Subject j is labeled xij • Effect of Trt i is labeled ai • Effect of Subject j is labeled bj • Random error term is labeled eij

  21. Dependent Samples - RBD • Model: • Test for differences among treatment effects: • H0: a1 = ... = aI= 0 (m1= ... = mI) • HA: Not all ai = 0 (Not all mi are equal)

  22. RBD - ANOVA F-Test (Normal Data) • Data Structure: (I Treatments, J Subjects or Blocks) • Mean for Treatment i: • Mean for Subject (Block) j: • Overall Mean: • Overall sample size: N = IJ • ANOVA:Treatment, Block, and Error Sums of Squares

  23. RBD - ANOVA F-Test (Normal Data) • ANOVA Table: • H0: a1 = ... = aI= 0 (m1= ... = mI) • HA: Not all ai = 0 (Not all mi are equal)

  24. Example - Theophylline Interaction • Goal: Determine whether Cimetidine or Famotidine interact with Theophylline • 3 Treatments: Theo/Cim, Theo/Fam, Theo/Placebo • 14 Blocks: Each subject received each treatment • Response: Theophylline clearance (liters/hour) Source: Bachmann, et al (1995)

  25. Example - Theophylline Interaction • The test for differences in mean theophylline clearance is given in the third line of the table • T.S.: Fobs=10.59 • R.R.:Fobs F.05,2,26 = 3.37 (From F-table) • P-value: .000 (Sig. Level)

  26. Example - Theophylline InteractionPost-hoc Comparisons

  27. Example - Theophylline InteractionPlot of Data (Marginal means are raw data)

  28. RBD -- Non-Normal DataFriedman’s Test • When data are non-normal, test is based on ranks • Procedure to obtain test statistic: • Rank the I treatments within each block (1=smallest, I=largest) adjusting for ties • Compute rank sums for treatments (Ri) across blocks • H0: The I populations are identical (m1=...=mI) • HA: Differences exist among the I group means

  29. Example - tmaxfor 3 formulation/fasting states • I=3 Treatments of Valproate: Capsule/Fasting (i=1), Capsule/nonfasting (i=2), Enteric-Coated/fasting (i=3) • J=11 subjects • Response - Time to maximum concentration (tmax) Source: Carrigan, et al (1990)

  30. Example - tmaxfor 3 formulation/fasting states • H0: The I populations are identical (m1=...=mI) • HA: Differences exist among the I group means

  31. Data Sources • Lee,D.W., K.W. Chan, C.M. Poon, et al (2002). “Relaxation Music Decreases the Dose of Patient-Controlled Sedation During Colonoscopy: A Prospective Randomized Controlled Trial,” Gastrointestinal Endoscopy, 55:33-36. • Klausner,J.D., S. Makonkawkeyoon, P. Akarasewi, et al (1996). “The Effect of Thalidomide on the Pathogenesis of HIV-1 and M. tuberculosis Infection,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11:247-257 • Bachmann, K., T.J. Sullivan, J.H. Reese, et al (1995). “Controlled Study of the Putative Interaction Between Famotidine and Theophylline in Patients with Chronic Obstructive Pulmonary Disorder,” Journal of Clinical Pharmacology, 35:529-535.

More Related